Human CDHR3/CDH28 ORF/cDNA clone-Lentivirus particle (NM_152750)

Cat. No.: vGMLP004355

Pre-made Human CDHR3/CDH28 Lentiviral expression plasmid for CDHR3 lentivirus packaging, CDHR3 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to CDHR3/CDH28 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP004355 Human CDHR3 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP004355
Gene Name CDHR3
Accession Number NM_152750
Gene ID 222256
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2658 bp
Gene Alias CDH28
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCAGGAAGCAATCATTCTCCTGGCTCTCCTGGGTGCCATGTCAGGGGGAGAAGCACTACACCTAATCCTCTTACCTGCTACAGGCAATGTGGCAGAGAATTCTCCACCTGGGACTTCAGTGCACAAGTTTTCTGTGAAGTTATCAGCATCATTGTCACCTGTGATCCCAGGATTTCCCCAGATAGTCAACTCAAATCCCCTCACTGAAGCTTTTAGGGTGAATTGGCTGTCAGGCACCTACTTTGAGGTTGTCACCACTGGGATGGAACAACTAGATTTTGAAACAGGACCAAACATATTTGATTTGCAGATTTATGTGAAGGATGAGGTTGGTGTCACAGACCTGCAAGTCCTGACTGTCCAGGTAACAGATGTGAACGAGCCACCTCAGTTTCAAGGCAACTTGGCAGAAGGTCTACACCTCTACATAGTAGAAAGAGCAAACCCTGGATTCATTTACCAGGTTGAGGCCTTCGATCCAGAAGACACAAGCCGAAACATTCCCCTCAGTTATTTCCTGATTTCTCCCCCAAAGAGCTTCAGAATGTCTGCTAATGGCACCCTCTTCTCCACAACAGAATTGGACTTTGAAGCAGGACACAGAAGTTTCCATCTCATCGTGGAGGTGAGGGACAGTGGAGGCCTCAAAGCCTCCACAGAGCTCCAGGTGAACATCGTGAACCTCAACGACGAAGTCCCTCGCTTTACCAGCCCGACACGAGTGTACACAGTCCTGGAGGAACTGAGTCCAGGAACCATCGTGGCCAATATCACAGCGGAGGATCCTGATGATGAAGGTTTTCCCAGCCACCTCCTCTACAGCATTACCACTGTTAGCAAATATTTCATGATAAATCAGTTGACTGGTACAATCCAAGTGGCCCAAAGGATAGACCGAGATGCAGGTGAATTGAGACAAAATCCCACCATTTCCCTGGAAGTTCTAGTGAAGGACAGACCATATGGGGGTCAGGAGAATCGCATCCAGATAACCTTCATTGTGGAAGACGTCAACGACAATCCTGCCACATGCCAAAAGTTCACCTTCAGCATTATGGTGCCGGAAAGAACAGCCAAGGGGACGTTGCTTCTTGACCTAAACAAGTTCTGCTTTGATGATGACAGTGAGGCACCAAACAACAGATTCAACTTCACCATGCCATCTGGAGTGGGGAGCGGCAGCAGATTTTTACAGGATCCAGCTGGCTCTGGGAAGATTGTGCTGATTGGTGATCTAGACTACGAAAATCCAAGTAACCTAGCAGCCGGCAATAAATATACGGTGATAATCCAGGTGCAGGATGTGGCCCCCCCTTACTATAAAAATAACGTCTACGTTTATATCCTAACAAGCCCAGAAAATGAGTTTCCTCTCATTTTTGATAGGCCATCCTATGTATTTGATGTGTCAGAAAGAAGGCCCGCCAGAACCCGAGTGGGACAGGTGCGAGCCACTGATAAAGACCTCCCCCAGAGCAGCCTCCTGTACTCCATCTCCACTGGAGGGGCCAGCCTCCAGTATCCAAATGTATTTTGGATTAATCCCAAGACAGGAGAACTCCAGCTGGTAACTAAAGTGGACTGTGAAACAACCCCCATCTATATTCTCAGAATCCAGGCCACCAACAACGAAGACACAAGCTCTGTCACTGTTACTGTGAACATCCTTGAAGAAAATGATGAAAAGCCAATTTGTACTCCAAACTCTTATTTCCTGGCCCTCCCAGTGGATCTGAAAGTTGGCACAAATATTCAGAATTTCAAGCTGACATGTACCGACCTTGATTCCAGCCCCAGATCTTTCCGTTATTCCATTGGCCCAGGTAACGTCAACAATCATTTCACCTTCTCTCCCAATGCTGGTTCCAATGTCACACGCCTGCTGCTTACATCTCGCTTTGACTATGCTGGTGGGTTTGATAAGATCTGGGACTACAAGCTACTTGTCTACGTAACTGATGACAACTTGATGTCTGACAGGAAGAAAGCGGAGGCTCTTGTTGAGACAGGAACAGTGACACTGAGTATTAAAGTCATTCCCCACCCAACCACTATCATCACCACGACCCCCAGGCCCAGGGTCACCTATCAGGTCCTGAGGAAAAACGTTTACTCTCCATCTGCATGGTACGTGCCGTTTGTCATCACTTTGGGCTCCATATTGCTTCTGGGTCTCCTCGTGTACCTGGTCGTCCTATTGGCCAAAGCCATCCACAGACACTGCCCCTGCAAGACTGGGAAGAACAAGGAACCTCTGACAAAGAAAGGAGAAACGAAGACTGCAGAGAGAGACGTCGTGGTGGAAACTATCCAGATGAACACTATCTTTGATGGAGAAGCCATAGATCCAGTGACCGGGGAAACATATGAATTCAACTCAAAAACTGGAGCCAGAAAGTGGAAAGATCCACTAACCCAAATGCCAAAATGGAAAGAGTCCAGCCACCAGGGAGCTGCCCCACGCAGAGTCACTGCTGGGGAAGGGATGGGGTCACTGAGAAGTGCCAACTGGGAAGAAGATGAGCTGAGTGGCAAAGCGTGGGCTGAGGATGCTGGTCTGGGTTCCAGAAATGAGGGTGGCAAGCTGGGCAACCCAAAGAACAGAAATCCAGCCTTCATGAACAGGGCTTACCCCAAACCACACCCAGGAAAGTAA
ORF Protein Sequence MQEAIILLALLGAMSGGEALHLILLPATGNVAENSPPGTSVHKFSVKLSASLSPVIPGFPQIVNSNPLTEAFRVNWLSGTYFEVVTTGMEQLDFETGPNIFDLQIYVKDEVGVTDLQVLTVQVTDVNEPPQFQGNLAEGLHLYIVERANPGFIYQVEAFDPEDTSRNIPLSYFLISPPKSFRMSANGTLFSTTELDFEAGHRSFHLIVEVRDSGGLKASTELQVNIVNLNDEVPRFTSPTRVYTVLEELSPGTIVANITAEDPDDEGFPSHLLYSITTVSKYFMINQLTGTIQVAQRIDRDAGELRQNPTISLEVLVKDRPYGGQENRIQITFIVEDVNDNPATCQKFTFSIMVPERTAKGTLLLDLNKFCFDDDSEAPNNRFNFTMPSGVGSGSRFLQDPAGSGKIVLIGDLDYENPSNLAAGNKYTVIIQVQDVAPPYYKNNVYVYILTSPENEFPLIFDRPSYVFDVSERRPARTRVGQVRATDKDLPQSSLLYSISTGGASLQYPNVFWINPKTGELQLVTKVDCETTPIYILRIQATNNEDTSSVTVTVNILEENDEKPICTPNSYFLALPVDLKVGTNIQNFKLTCTDLDSSPRSFRYSIGPGNVNNHFTFSPNAGSNVTRLLLTSRFDYAGGFDKIWDYKLLVYVTDDNLMSDRKKAEALVETGTVTLSIKVIPHPTTIITTTPRPRVTYQVLRKNVYSPSAWYVPFVITLGSILLLGLLVYLVVLLAKAIHRHCPCKTGKNKEPLTKKGETKTAERDVVVETIQMNTIFDGEAIDPVTGETYEFNSKTGARKWKDPLTQMPKWKESSHQGAAPRRVTAGEGMGSLRSANWEEDELSGKAWAEDAGLGSRNEGGKLGNPKNRNPAFMNRAYPKPHPGK

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP0242-Ab Anti-CDHR3/ CDH28 monoclonal antibody
    Target Antigen GM-Tg-g-MP0242-Ag CDHR3 VLP (virus-like particle)
    ORF Viral Vector pGMLP004355 Human CDHR3 Lentivirus plasmid
    ORF Viral Vector vGMLP004355 Human CDHR3 Lentivirus particle


    Target information

    Target ID GM-MP0242
    Target Name CDHR3
    Gene ID 222256, 68764, 698235, 686932, 101081877, 475891, 786198, 100059168
    Gene Symbol and Synonyms 1110049B09Rik,CDH28,CDHR3
    Uniprot Accession Q6ZTQ4
    Uniprot Entry Name CDHR3_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000128536
    Target Classification Not Available

    Predicted to enable cadherin binding activity and calcium ion binding activity. Predicted to be involved in calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; cell morphogenesis; and cell-cell junction organization. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.